All News
Filter News
Found 31 articles
-
Anima Biotech, based in Bernardsville, New Jersey, inked a discovery and development deal with Eli Lilly and Co. that has the potential to exceed $1 billion.
-
Anima Biotech Announces an Exclusive Collaboration With Lilly for the Discovery and Development of Translation Inhibitors of Several Protein Targets
7/23/2018
Anima Biotech today announced an agreement with Lilly for the discovery and development of translation inhibitors.
-
One of the growing areas in the medical device industry is new approaches to drug delivery. Here are the top 5 drug delivery companies that you must be aware of.
-
Zynerba Appoints Richard A. Baron VP And CFO
1/5/2015
-
Medtronic, Inc., Johnson & Johnson Settle Patent Spat
8/14/2014
-
Advances In Predictive Hypoglycemia-Minimizing Technology From Animas Corporation-JDRF Collaboration At American Diabetes Association Scientific Sessions
6/16/2014
-
Animas Corporation Release: Animas® Vibe Insulin Pump And Dexcom G4 PLATINUM CGM System Is Now Approved For Children With Type 1 Diabetes
3/6/2014
-
Continuous Glucose Monitoring (CGM) Market Will Reach $568.5 Million Globally By 2020 - Allied Market Research
12/23/2013
-
Hacker Demonstrates Just How Vulnerable Johnson & Johnson's Insulin Pump Really Is
8/2/2013
-
Animas Corporation Makes Progress in Development of a First-Generation Closed-Loop Insulin Delivery System With Study Participants Maintaining Safe Glucose Levels for Over 90 Percent of the Overnight Period
6/24/2013
-
The Day In Review: Novartis Corporation Dumps Statin Drug Development
12/16/2005